L-Dopa is the prodrug of dopamine (DA), which has no pharmacological activity itself, enters the center through the blood-brain barrier, and is converted into DA by the action of dopa decarboxylase to exert pharmacological effects.
This report contains market size and forecasts of L-Dopa in global, including the following market information:
Global L-Dopa Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global L-Dopa Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five L-Dopa companies in 2021 (%)
The global L-Dopa market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity: 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of L-Dopa include Ajinomoto, Daiichi Sankyo, Divis Laboratories, Tiefenbacher API + Ingredients, Teva Pharmaceutical Industries, Xinhua Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Wild Wind Pharmaceutical and JL Pharm and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the L-Dopa manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global L-Dopa Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global L-Dopa Market Segment Percentages, by Type, 2021 (%)
Purity: 98%
Purity: 99%
Global L-Dopa Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global L-Dopa Market Segment Percentages, by Application, 2021 (%)
Parkinson Disease Medicine
Hepatic Encephalopathy Medicine
Others
Global L-Dopa Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global L-Dopa Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies L-Dopa revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies L-Dopa revenues share in global market, 2021 (%)
Key companies L-Dopa sales in global market, 2017-2022 (Estimated), (Tons)
Key companies L-Dopa sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ajinomoto
Daiichi Sankyo
Divis Laboratories
Tiefenbacher API + Ingredients
Teva Pharmaceutical Industries
Xinhua Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Wild Wind Pharmaceutical
JL Pharm
ChenLv Herb